Major Symposium G: Therapeutic and Translational Immunology (Duplicate)

Chair(s)

• JG

  Jane Grogan

  Head of Research
  Biogen, USA
• JS

  Jamie Spangler

  Associate Professor
  Johns Hopkins Univ., USA

Speaker(s)

• 

  Donna Flesher, PhD (she/her/hers)

  Head of Biomarkers and Clinical Pharmacology, Biogen West Coast Hub
  Biogen, United States
• SR

  Sai Reddy

  Associate Professor
  ETH Zurich, DEU
• FM

  Faez Amokrane Mohamed

  Harvard Med. Sch., USA
• JS

  Jamie Spangler

  Associate Professor
  Johns Hopkins Univ., USA
• 

  James Torchia, MD, PhD

  Instructor in Medicine
  Department of Medical Oncology
  Dana-Farber Cancer Institute, Harvard Medical School, United States
• JH

  John Harris

  Professor
  Mass Gen. Brigham, United States
• MB

  Michael Birnbaum, PhD

  Associate Professor
  MIT, United States

Presentations:

• 8:00 AM - 8:33 AM US ET

  From signal to strategy: Integrating biomarkers in clinical trials to accelerate drug development in transplant
  

  Speaker: Donna Flesher, PhD (she/her/hers) – Biogen
• 8:33 AM - 9:06 AM US ET

  Generative design of antibody Fc variants with synthetic and programmable immune function
  

  Speaker: Sai Reddy – ETH Zurich
• 9:06 AM - 9:21 AM US ET

  Intranasal administration of a pan-reactive influenza antibody reveals Fc-independent mode of protection
  

  Author: Faez Amokrane Nait Mohamed, PhD (he/him/his) – Harvard Medical School
• 9:21 AM - 9:54 AM US ET

  Engineering cytokine/antibody fusion proteins as targeted immunotherapeutics
  

  Speaker: Jamie Spangler – Johns Hopkins Univ.
• 9:54 AM - 10:09 AM US ET

  Targeted immunosuppression with a tissue-selective PD-1 agonist prevents rejection of transplanted hearts
  

  Author: James A. Torchia, MD, PhD – Dana-Farber Cancer Institute, Harvard Medical School
• 10:09 AM - 10:42 AM US ET

  Vitiligo treatment from the Bronze Age to the Age of Biologics: New hope for an ancient disease
  

  Speaker: John E. Harris – Mass Gen. Brigham
• 10:42 AM - 11:15 AM US ET

  Decoding adaptive immunity
  

  Speaker: Michael Birnbaum, PhD – MIT